The RADx® Tech program is a component of the overarching RADx Initiative at NIH to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. RADx Tech for COVID-19 was designed to compress the customary technology development timeline from years down to just months. This was accomplished by employing, in parallel, expert teams to address technical, regulatory, clinical, and commercialization requirements. Launched on April 29, 2020, the RADx Tech programs were able to validate, de-risk, scale up, manufacture, and deploy novel tests through a seamless pipeline. In addition, the Independent Test Assessment Program (ITAP) in collaboration with the FDA helped to accelerate authorization of tests from outside the U.S. and rapidly increase testing capacity during the Omicron variant surge and supported development of multiplex tests to detect COVID-19 and flu.
These programs increased testing capacity in the U.S. by billions. As the COVID-19 pandemic evolves, NIBIB continues to support projects to fill unmet needs in diagnostic testing.
Learn how these programs are now being leveraged to meet the needs of health challenges beyond the COVID-19 pandemic on the RADx Innovation Funnel page.
This website is an easy way to anonymously report test results for at-home COVID-19 or flu tests. This helps public health departments to assess needs and provide resources. Report your test results here.
This effort established a secure way to send results from at-home tests to public health systems. The process is designed to work with different tests and includes an option for anonymous reporting.
List of RADx Tech and ITAP supported lab, point-of-care, and over-the-counter/at-home tests and test products that have received emergency use authorization (EUA) or traditional market authorization from the U.S. Food and Drug Administration (FDA).
See the milestones and success that have unfolded since the beginning of the RADx Tech program.
Ongoing effort to work with collaborators to develop at-home diagnostic tests for COVID-19 that can be used independently by people with disabilities.
Summary data on proposals submitted, types of diagnostic tests and products, and test production capacity between April 2020 and March 2023.
Read an overview of the RADx Tech program and the impact on addressing the COVID-19 pandemic.
Program Contacts
RADx® Tech programmatic or technical inquiries: info.radx@poctrn.org
All other RADx® Tech Applicants: RADxNIBIB@mail.nih.gov
SBIR/STTR Applicants: NIBIB-SBIR@mail.nih.gov
All others: COVID19Grants@nih.gov